1
Palmieri C, Bird E, Simcock R, editors. ABC of cancer care. Chichester: : Wiley-Blackwell 2013.
2
Carlo P. ABC of Cancer Care. 1st ed. John Wiley & Sons, Incorporated 2013. https://ebookcentral.proquest.com/lib/suss/detail.action?docID=1207852
3
Cabot, Richard CHarris, Nancy Lee, MDRosenberg, Eric S, MDShepard, Jo-Anne O, MDCort, Alice M, MD. Case 14-2013. The New England Journal of Medicine;368:1827–35.http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1349803228/99B6F5EFE846490BPQ/39?accountid=9727
4
Kaye P. Breaking bad news: a 10 step approach. Northampton: : EPL 1996.
5
Jonathan Silverman, Suzanne Kurtz, and Juliet Draper. Skills for Communicating with Patients, 3rd Edition. 3rd ed. Chapman and Hall/CRC 2016. https://ebookcentral.proquest.com/lib/ubrighton/detail.action?docID=4742673
6
Silverman J, Kurtz SM, Draper J. Skills for communicating with patients. Third edition. London: : Radcliffe Publishing 2013.
7
Kurtz SM, Silverman J, Draper J. Teaching and learning communication skills in medicine. 2nd ed. Abingdon: : Radcliffe 2005. https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS2175116780002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&tab=default&lang=en_US
8
Adler DD, Riba MB, Eggly S. Breaking Bad News in the Breast Imaging Setting. Academic Radiology 2009;16:130–5. doi:10.1016/j.acra.2008.08.006
9
Fujimori M, Uchitomi Y. Preferences of Cancer Patients Regarding Communication of Bad News: A Systematic Literature Review. Japanese Journal of Clinical Oncology 2009;39:201–16. doi:10.1093/jjco/hyn159
10
Hanratty, BarbaraLowson, ElizabethHolmes, LouiseGrande, GunnJacoby, Ann. Breaking bad news sensitively: what is important to patients in their last year of life? BMJ Supportive & Palliative Care;2:53–9.https://search.proquest.com/docview/1783997881/fulltext/D9074EB1CBE345A7PQ/1?accountid=9727
11
Hamilton, W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. The British Journal of Cancer;101.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790706/
12
Alfred G. Knudson, Jr. Mutation and Cancer: Statistical Study of Retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America 1971;68.https://www-jstor-org.sussex.idm.oclc.org/stable/60687?sid=primo
13
Gawande A, Wellcome Collection. Being mortal: illness, medicine and what matters in the end. London: : Profile Books 2015.
14
Being Mortal. 2014.https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS51112977480002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&isFrbr=true&tab=default&lang=en_US
15
Mukherjee S. The emperor of all maladies: a biography of cancer. London: : Fourth Estate 2011. https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS2189620360002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&tab=default&lang=en_US
16
Clark S. A guide to cancer genetics in clinical practice. Harley: : TFM 2009.
17
Firth HV, Hurst JA, Hall JG. Oxford desk reference: clinical genetics. Oxford: : Oxford University Press 2005.
18
Gene Reviews via the NCBI website : National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/
19
OMIM - Online Mendelian Inheritance in Man. https://omim.org/
20
Sorace J, Aberle DR, Elimam D, et al. Integrating pathology and radiology disciplines: an emerging opportunity? BMC Medicine 2012;10. doi:10.1186/1741-7015-10-100
21
Royal College of Pathologists datasets for histopathology reporting on cancers. https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html
22
Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell 2000;100:57–70. doi:10.1016/S0092-8674(00)81683-9
23
Husband JE, Reznek RH. Husband & Reznek’s imaging in oncology. 3rd ed. London: : Informa Healthcare 2010. http://www.vlebooks.com/vleweb/product/openreader?id=Brighton&isbn=9780415874984
24
American Joint Committee on Cancer. AJCC cancer staging handbook: from the AJCC Cancer staging manual. 7th ed. London: : Springer 2010. https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS2188698760002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&tab=default&lang=en_US
25
Grégoire V, Ang K, Budach W, et al. Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiotherapy and Oncology 2014;110:172–81. doi:10.1016/j.radonc.2013.10.010
26
Li B, Li Q, Nie W, et al. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: A meta-analysis. European Journal of Radiology 2014;83:338–44. doi:10.1016/j.ejrad.2013.11.017
27
Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls: American Journal of Roentgenology. American Journal of Roentgenologyhttps://www.ajronline.org/doi/abs/10.2214/AJR.11.7866
28
Goh V, Ng QS, Miles K. Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology? 2012;47.https://contentstore.cla.co.uk/secure/link?id=0968f686-0873-e911-80cd-005056af4099
29
Imaging for Staging and Response Assessment in Lymphoma : Radiology. http://pubs.rsna.org.ezproxy.brighton.ac.uk/doi/full/10.1148/radiol.2015142088
30
Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. Journal of Clinical Oncology 2014;32:3059–67. doi:10.1200/JCO.2013.54.8800
31
Dimopoulos MA, Hillengass J, Usmani S, et al. Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement. Journal of Clinical Oncology 2015;33:657–64. doi:10.1200/JCO.2014.57.9961
32
Dow-Mu Koh, Matthew Blackledge, Anwar R. Padhani et al. Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls. https://www.ajronline.org/doi/abs/10.2214/AJR.11.7866
33
Berland LL, Silverman SG, Gore RM, et al. Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee. Journal of the American College of Radiology 2010;7:754–73. doi:10.1016/j.jacr.2010.06.013
34
Gore RM, Wenzke DR, Thakrar KH, et al. The incidental cystic pancreas mass: a practical approach. Cancer Imaging 2012;12:414–21. doi:10.1102/1470-7330.2012.9054
35
Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST : American Journal of Roentgenology. http://www.ajronline.org.ezproxy.brighton.ac.uk/doi/abs/10.2214/AJR.11.7483
36
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). European Journal of Cancer 2009;45:228–47. doi:10.1016/j.ejca.2008.10.026
37
Response Criteria in Oncologic Imaging: Review of Traditional and New Criteria : RadioGraphics. http://pubs.rsna.org/doi/full/10.1148/rg.335125214
38
A Radiologist’s Guide to Treatment Response Criteria in Oncologic Imaging: Anatomic Imaging Biomarkers : American Journal of Roentgenology. http://www.ajronline.org.ezproxy.brighton.ac.uk/doi/abs/10.2214/AJR.12.9862
39
Neoplastic Invasion of Laryngeal Cartilage: Reassessment of Criteria for Diagnosis at MR Imaging. https://pubs.rsna.org/doi/10.1148/radiol.2492072183
40
Vardy J, Engelhardt K, Cox K, et al. Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. British Journal of Cancer 2004;91:1045–9. doi:10.1038/sj.bjc.6602082
41
Mehanna, HishamWong, Wai-LupMcConkey, Christopher CRahman, Joy KRobinson, Max. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer. The New England Journal of Medicine;374:1444–54.http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1781205526/AECA702A9F2C499DPQ/4?accountid=9727
42
Balaji Ganeshan. Quantifying tumour heterogeneity with CT. Cancer Imaging 2013;13. doi:doi: 10.1102/1470-7330.2013.0015
43
British Thyroid Association Guidelines. https://www.british-thyroid-association.org/current-bta-guidelines-and-statements
44
British Thoracic Society Guidelines for the investigation and management of pulmonary nodules. https://www.brit-thoracic.org.uk/document-library/clinical-information/pulmonary-nodules/bts-guidelines-for-pulmonary-nodules/
45
NICE Suspected cancer: recognition and referral | Guidance and guidelines. https://www.nice.org.uk/guidance/ng12?unlid=9874814692015129115552,5161700902016923910
46
Fleissig, AnneJenkins, ValerieCatt, SusanFallowfield, Lesley. Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncology;7:935–43.http://search.proquest.com.ezproxy.brighton.ac.uk/docview/200993543/B199001EC4DE4BBFPQ/31?accountid=9727
47
Munro AJ. Multidisciplinary Team Meetings in Cancer Care: An Idea Whose Time has Gone? Clinical Oncology 2015;27:728–31. doi:10.1016/j.clon.2015.08.008
48
Jalil R, Ahmed M, Green JSA, et al. Factors that can make an impact on decision-making and decision implementation in cancer multidisciplinary teams: An interview study of the provider perspective. International Journal of Surgery 2013;11:389–94. doi:10.1016/j.ijsu.2013.02.026
49
Lamb B, Payne H, Vincent C, et al. The role of oncologists in multidisciplinary cancer teams in the UK: an untapped resource for team leadership? Journal of Evaluation in Clinical Practice 2011;17:1200–6. doi:10.1111/j.1365-2753.2010.01507.x
50
NHS Cancer Action Team: Quality in Nursing: Excellence in Cancer Care: The contribution of the Clinical Nurse Specialist. https://www.macmillan.org.uk/documents/aboutus/commissioners/excellenceincancercarethecontributionoftheclinicalnursespecialist.pdf
51
Clark D, Armstrong M, Allan A, et al. Imminence of death among hospital inpatients: Prevalent cohort study. Palliative Medicine 2014;28:474–9. doi:10.1177/0269216314526443
52
Costantini M, Romoli V, Leo SD, et al. Liverpool Care Pathway for patients with cancer in hospital: a cluster randomised trial. The Lancet 2014;383:226–37. doi:10.1016/S0140-6736(13)61725-0
53
Campion, Edward WKelley, Amy SMorrison, R Sean. Palliative Care for the Seriously Ill. The New England Journal of Medicine;373:747–55.http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1705787576/C2817B3DB58F4ADCPQ/8?accountid=9727
54
May P, Garrido MM, Cassel JB, et al. Prospective Cohort Study of Hospital Palliative Care Teams for Inpatients With Advanced Cancer: Earlier Consultation Is Associated With Larger Cost-Saving Effect. Journal of Clinical Oncology 2015;33:2745–52. doi:10.1200/JCO.2014.60.2334
55
Temel, Jennifer S, MDGreer, Joseph A, PhDMuzikansky, Alona, MAGallagher, Emily R, RNAdmane, Sonal, MB, BS, MPH. Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer. The New England Journal of Medicine;363:733–42.http://search.proquest.com.ezproxy.brighton.ac.uk/docview/746045208/D2D08130C77249DFPQ/1?accountid=9727
56
National Confidential Enquiry into Patient Outcome and Death. https://www.ncepod.org.uk/2008report3/Downloads/SACT_report.pdf
57
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. The New England Journal of Medicine;365:395–409.http://search.proquest.com.ezproxy.brighton.ac.uk/docview/881546508/4102C883EC5E4D19PQ/3?accountid=9727
58
Black, William CGareen, Ilana FSoneji, Samir SSicks, JoRean DKeeler, Emmett B. Cost-Effectiveness of CT Screening in the National Lung Screening Trial. The New England Journal of Medicine;371:1793–802.http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1621375459/F618EBF5604B46B2PQ/2?accountid=9727
59
Jefford M, Rowland J, Grunfeld E, et al. Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA. British Journal of Cancer 2013;108:14–20. doi:10.1038/bjc.2012.554
60
Living with and Beyond Cancer. Taking Action to Improve Outcomes. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/181054/9333-TSO-2900664-NCSI_Report_FINAL.pdf
61
DeVita VT, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. Tenth edition. Philadelphia: : Wolters Kluwer 2015.
62
DeVita, Hellman, and Rosenberg’s Cancer : Principles & Practice of Oncology. 10th ed. Wolters Kluwer Health 2014. https://ebookcentral.proquest.com/lib/suss/detail.action?docID=2035697
63
Hoskin PJ. External beam therapy. 2nd ed. Oxford: : Oxford University Press 2012.
64
Hoskin PJ, Coyle C. Brachytherapy. 2nd ed. Oxford: : Oxford University Press 2011.
65
Hoskin PJ, Goh V. Imaging. Oxford: : Oxford University Press 2009.
66
Hoskin PJ. Radioisotope therapy. Oxford: : Oxford University Press 2007.
67
Practical Radiotherapy Planning: Contouring Atlases. https://www.rtog.org/CoreLab/ContouringAtlases.aspx
68
Arends J, Bodoky G, Bozzetti F, et al. ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clinical Nutrition 2006;25:245–59. doi:10.1016/j.clnu.2006.01.020
69
Burnet NG. Defining the tumour and target volumes for radiotherapy. Cancer Imaging 2004;4:153–61. doi:10.1102/1470-7330.2004.0054
70
Tokuhashi Y, Matsuzaki H, Oda H, et al. A Revised Scoring System for Preoperative Evaluation of Metastatic Spine Tumor Prognosis. Spine 2005;30:2186–91. doi:10.1097/01.brs.0000180401.06919.a5
71
Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition | Guidance and guidelines | NICE. https://www.nice.org.uk/guidance/cg32
72
Metastatic spinal cord compression in adults | Guidance and guidelines | NICE. https://www.nice.org.uk/guidance/qs56
73
Neutropenic sepsis: prevention and management in people with cancer | Guidance and guidelines | NICE. https://www.nice.org.uk/guidance/cg151
74
NICE IPG79 (2004) Stent placement for vena caval obstruction. https://www.nice.org.uk/guidance/ipg79
75
MDT Development. http://www.ncin.org.uk/cancer_type_and_topic_specific_work/multidisciplinary_teams/mdt_development
